'Corning Announces Collaboration With NIBRT To Help Accelerate Cell Therapy Development'
Portfolio Pulse from Benzinga Newsdesk
Corning Incorporated (NYSE:GLW) has announced a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT) to integrate its Ascent® Fixed Bed Bioreactor System into NIBRT's training programs. This partnership aims to accelerate cell therapy development and expand Corning's presence in the European life sciences market.
June 18, 2024 | 2:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Corning's collaboration with NIBRT to integrate its Ascent® Fixed Bed Bioreactor System into training programs is likely to enhance its presence in the European life sciences market and accelerate cell therapy development.
The collaboration with NIBRT positions Corning to benefit from the growing demand for cell and gene therapies. The integration of the Ascent® Fixed Bed Bioreactor System into NIBRT's training programs will likely enhance Corning's visibility and credibility in the European market, potentially leading to increased sales and revenue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100